Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma, Ewing × Radiation Dose Hypofractionation × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 9 Liposarcoma, Myxoid 3 Sarcoma, Synovial 2 Neurofibrosarcoma 2 Liposarcoma 2 Leiomyosarcoma 2 Histiocytoma, Malignant Fibrous 2 Fibrosarcoma 2 Sarcoma, Ewing 1 Sarcoma, Clear Cell 1 Sarcoma, Alveolar Soft Part 1 Neoplasms, Radiation-Induced 1 Myosarcoma 1 Lymphangiosarcoma 1 Hyperthermia 1 Histiocytic Sarcoma 1 Dermatofibrosarcoma 1

Interventions

Cyclophosphamide 24 Temozolomide 21 Irinotecan 18 Vincristine 17 Doxorubicin 13 Topotecan 10 Melphalan 10 Etoposide 10 Ifosfamide 8 Busulfan 8 Magnetic Resonance Spectroscopy 7 Granulocyte Colony-Stimulating Factor 7 Filgrastim 6 cabozantinib 5 X-Rays 5 Specimen Handling 5 Sirolimus 5 Drug Therapy 5 regorafenib 4 pegfilgrastim 4 palbociclib 4 liposomal doxorubicin 4 fludarabine phosphate 4 fludarabine 4 Trabectedin 4 Radiotherapy 4 Phantoms, Imaging 4 Nivolumab 4 Gemcitabine 4 FANG vaccine 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07188532 2026-01-23

BEAR

Mayo Clinic

Phase NA Recruiting

Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon ⚡